Objectives:

1. Examine the mechanisms and current therapies underlying the association between venous thromboembolism and cancer
2. Identify various anticoagulation strategies and mechanisms of reducing thrombosis in malignancy
3. Summarize the current targeted agents on factor XI inhibition and upcoming clinical trials

Zoom info:

Join from a PC, Mac, iPad, iPhone or Android device: Passcode: Grand

    Please click this URL to join. https://uwmadison.zoom.us/s/98612887803?pwd=cWV4TE1uV2I2dWpMczZOVU1GTXhlUT09

  Or One tap mobile:  +13126266799,,98612887803# US (Chicago); +16469313860,,98612887803# US

Or join by phone:

    Dial(for higher quality, dial a number based on your current location):

        US: +1 312 626 6799  or +1 646 931 3860  or +1 929 205 6099  or +1 301 715 8592  or +1 305 224 1968  or +1 309 205 3325  or +1 719 359 4580  or +1 253 205 0468  or +1 253 215 8782  or +1 346 248 7799  or +1 360 209 5623  or +1 386 347 5053  or +1 507 473 4847  or +1 564 217 2000  or +1 669 444 9171  or +1 669 900 6833  or +1 689 278 1000

    Webinar ID: 986 1288 7803

    International numbers available: https://uwmadison.zoom.us/u/aeta0EfvuU

Or an H.323/SIP room system:  H.323: 162.255.37.11 (US West) or 162.255.36.11 (US East); Webinar ID: 986 1288 7803; Passcode: 060507;

SIP: 98612887803@zoomcrc.com; Passcode: 060507